Grassi Investment Management Has $707,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Grassi Investment Management grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 72.0% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 1,350 shares of the healthcare conglomerate’s stock after buying an additional 565 shares during the period. Grassi Investment Management’s holdings in UnitedHealth Group were worth $707,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Capital & Planning LLC grew its stake in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after buying an additional 79 shares during the last quarter. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $27,233,000. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Finally, Tempus Wealth Planning LLC grew its stake in shares of UnitedHealth Group by 16.4% during the fourth quarter. Tempus Wealth Planning LLC now owns 1,003 shares of the healthcare conglomerate’s stock valued at $507,000 after purchasing an additional 141 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 in the last quarter. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.3%

Shares of UNH stock opened at $300.37 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm’s fifty day moving average price is $418.00 and its two-hundred day moving average price is $488.12. The firm has a market capitalization of $272.48 billion, a P/E ratio of 19.38, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the business earned $6.91 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. Robert W. Baird cut their price objective on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. TD Securities restated a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $428.43.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.